Brightstone Venture Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Celcuity is a commercial-stage biotechnology company developing targeted cancer therapies for tumors involving the PAM (PI3K/AKT/mTOR) pathway, including breast, prostate, lung, endometrial, colon, and ovarian cancers.
BiotechHealthtechMedical DevicesMinneapolis, US
Lance G. Laing(Executive Officer, Director, Promoter)Brian F. Sullivan(Executive Officer, Director, Promoter)inVicky Hahne(Executive Officer)
BoardDavid F. Dalvey(Director)inRichard E. Buller(Director)Leo T. Furcht(Director)
Board seatDavid Dalvey· per SEC Form D
Co-investorsNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.